Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Folate and nutrients involved in the 1-carbon cycle in the pretreatment of patients for colorectal cancer.

Ferrari A, de Carvalho AM, Steluti J, Teixeira J, Marchioni DM, Aguiar S Jr.

Nutrients. 2015 Jun 2;7(6):4318-35. doi: 10.3390/nu7064318.

2.

Gene-diet interactions and their impact on colorectal cancer risk.

Kantor ED, Giovannucci EL.

Curr Nutr Rep. 2015 Mar;4(1):13-21.

3.

Vitamin B6 and colorectal cancer: current evidence and future directions.

Zhang XH, Ma J, Smith-Warner SA, Lee JE, Giovannucci E.

World J Gastroenterol. 2013 Feb 21;19(7):1005-10. doi: 10.3748/wjg.v19.i7.1005. Review.

4.

Prospective cohort studies of vitamin B-6 intake and colorectal cancer incidence: modification by time?

Zhang X, Lee JE, Ma J, Je Y, Wu K, Willett WC, Fuchs CS, Giovannucci EL.

Am J Clin Nutr. 2012 Oct;96(4):874-81. Epub 2012 Aug 8.

5.

Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study.

Le Marchand L, Wang H, Selhub J, Vogt TM, Yokochi L, Decker R.

Cancer Causes Control. 2011 Jun;22(6):929-36. doi: 10.1007/s10552-011-9759-y. Epub 2011 Mar 25.

6.

Recent advances in understanding of interactions between genes and diet in the etiology of colorectal cancer.

Ferguson LR.

World J Gastrointest Oncol. 2010 Mar 15;2(3):125-9. doi: 10.4251/wjgo.v2.i3.125.

7.

Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.

Wallace K, Grau MV, Levine AJ, Shen L, Hamdan R, Chen X, Gui J, Haile RW, Barry EL, Ahnen D, McKeown-Eyssen G, Baron JA, Issa JP.

Cancer Prev Res (Phila). 2010 Dec;3(12):1552-64. doi: 10.1158/1940-6207.CAPR-10-0047.

8.

Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer.

de Vogel S, Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij AF, de Bruïne AP, Goldbohm RA, van den Brandt PA, van Engeland M, Weijenberg MP.

Cancer Causes Control. 2011 Jan;22(1):1-12. doi: 10.1007/s10552-010-9659-6. Epub 2010 Oct 20.

9.

Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk.

Eussen SJ, Vollset SE, Hustad S, Midttun Ø, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Boffetta P, Overvad K, Thorlacius-Ussing O, Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Weikert C, Pischon T, Linseisen J, Kaaks R, Trichopoulou A, Zilis D, Katsoulis M, Palli D, Pala V, Vineis P, Tumino R, Panico S, Peeters PH, Bueno-de-Mesquita HB, van Duijnhoven FJ, Skeie G, Muñoz X, Martínez C, Dorronsoro M, Ardanaz E, Navarro C, Rodríguez L, VanGuelpen B, Palmqvist R, Manjer J, Ericson U, Bingham S, Khaw KT, Norat T, Riboli E.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2549-61. doi: 10.1158/1055-9965.EPI-10-0407. Epub 2010 Sep 2.

10.

Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study.

Le Marchand L, White KK, Nomura AM, Wilkens LR, Selhub JS, Tiirikainen M, Goodman MT, Murphy SP, Henderson BE, Kolonel LN.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2195-201. doi: 10.1158/1055-9965.EPI-09-0141.

11.

Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors.

Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1041-9. doi: 10.1158/1055-9965.EPI-08-0926. Epub 2009 Mar 31.

12.

Folic acid and risk of prostate cancer: results from a randomized clinical trial.

Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA.

J Natl Cancer Inst. 2009 Mar 18;101(6):432-5. doi: 10.1093/jnci/djp019. Epub 2009 Mar 10.

Items per page

Supplemental Content

Write to the Help Desk